阐释中医药治疗肺纤维化机制

阐释扶正通络消积三方分期治疗肺纤维化特征；形成作用显著、组分明确的组分方，阐释作用机制。

（1）Li Meng, Li Ya, Li Jiansheng, Zhao Peng, Bai Yunping, Feng Suxiang, Liu Xuefang, Wang Yang, Bian Qingqing, Li Junzi. Long-Term Effects of TCM Yangqing Kangxian Formula on Bleomycin-Induced Pulmonary Fibrosis in Rats via Regulating Nuclear Factor-κB Signaling. Evid Based Complement Alternat Med. 2017, 2017:2089027.

（2）Bai Yunping, Li Jiansheng, Zhao Peng, Li Ya, Li Meng, Feng Suxiang, Qin Yanqin, Tian Yange, Zhou Tiqiang. A Chinese Herbal Formula Ameliorates Pulmonary Fibrosis by Inhibiting Oxidative Stress via Upregulating Nrf2. Front Pharmacol. 2018, 9:628.

（3）Zhao Peng, Cai Zehui, Tian Yange, Li Junzi, Li Kangchen, Li Minyan, Bai Yunping, Li Jiansheng. Effective-compound combination inhibits the M2-like polarization of macrophages and attenuates the development of pulmonary fibrosis by increasing autophagy through mTOR signaling. Int Immunopharmacol. 2021, 101(Pt B):108360.

（4）李建生，陈龙飞，李亚，田燕歌，冀会鸽，刘冠汝，郭闪闪，卢灵灵，何慧慧，贾瑞．扶正通络消积三方分期治疗肺纤维化大鼠疗效评价．中华中医药杂志，2021，36(03):1671-1676.

（5）李建生，董浩然，郑万春，刘学芳，田燕歌，李君子，冯素香，任周新，赵鹏．金水缓纤方治疗肺纤维化的组分配伍研究．中草药，2021，52(13):3966-3979.